CMS Open Payments · Program Year 2024
Mid-Atlantic Surgical Systems, LLC
Mid-Atlantic Surgical Systems, LLC reported $92,437.73 across General Payments, Research, and Ownership to 919 physicians and teaching hospitals across 919 transactions.
- $92.4K Below-median payer
- All-tracks total
- 919 Above-median volume
- Transactions
- 919 Above-median reach
- Recipients
- +$36.4K
- General Payments vs PY2023
Mid-Atlantic Surgical Systems, LLC reported $92,437.73 across all CMS Open Payments tracks (General + Research + Ownership) to 919 physicians and teaching hospitals in Program Year 2024 - ranking #1204 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $92,437.73, averaging $100.59 per recipient.
How Mid-Atlantic Surgical Systems, LLC's $92.4K all-tracks total breaks down
Mid-Atlantic Surgical Systems, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
17/100
Total payments
F
11/100
Transaction volume
F
17/100
Physician reach
F
17/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer mid-atlantic-surgical-systems-llc Mid-Atlantic Surgical Systems, LLC
$92.4K · #1204/1,925 · 0.0% industry · PY2024
- TOT $92.4K
- RANK #1204
- SHARE 0.0%
- TXN 919
- RCP 919
- CAT 2
- GEN $92.4K
- ΔGEN +$36.4K
- TOP1 2.6%
- PY 2024
Volume peers
Nearest volume peer: Cardinal Health 110 LLC ($92.3K)
Mid-Atlantic Surgical Systems, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Mid-Atlantic Surgical Systems, LLC's CMS-reported General Payments increased by $36.4K (+65.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: MID-ATLANTIC SURGICAL SYSTEMS, LLCPY2023: MID-ATLANTIC SURGICAL SYSTEMS, LLCPY2024: Mid-Atlantic Surgical Systems, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $56,001.44
- PY2024
- $92,437.73
What the Data Shows for Mid-Atlantic Surgical Systems, LLC
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Mid-Atlantic Surgical Systems, LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 2 general-payment categories charted below, "Travel and Lodging" is the largest at $64.2K across 243 transactions, 69.4% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Travel and Lodging" leads Mid-Atlantic Surgical Systems, LLC's 2-category general-payment breakdown at $64.2K, 69.4% of the reported total.
How Mid-Atlantic Surgical Systems, LLC divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Travel and Lodging | $64.2K | 243 | 69.4% |
| Food and Beverage | $28.3K | 676 | 30.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $10,296.06 (11.1%) of $92,437.73 in this company's General Payments records across 318 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Mid-Atlantic Surgical Systems, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Matthew Varacallo
$2,374.78 across 14 reported transactions
- 2
Omar Yaldo
$2,246.30 across 22 reported transactions
- 3
Ashley Baird
$2,141.19 across 16 reported transactions
- 4
Robert Marsh
$1,789.72 across 6 reported transactions
- 5
Guang Ting Cong
$1,744.07 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Mid-Atlantic Surgical Systems, LLC ranks #1204 of 1,925 by total payments (bottom 38% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,699 of 1,838 by HHI (bottom 8% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- ANI Pharmaceuticals, Inc. : $1.1M total payments, HHI 98
- Arcutis Biotherapeutics, Inc. : $5.0M total payments, HHI 97
- CVRx, Inc. : $1.5M total payments, HHI 97
- Peerless Surgical Inc. : $139.0K total payments, HHI 96
- Gemini Mountain Medical, LLC : $85.4K total payments, HHI 96
- InSightec,Inc : $120.8K total payments, HHI 96
- Mid-Atlantic Surgical Systems, LLC (this company) : $92.4K total payments, HHI 95
- Tempus AI, Inc : $683.5K total payments, HHI 95
- Validus Pharmaceuticals LLC : $12.3K total payments, HHI 95
- CSL Behring : $4.9M total payments, HHI 91
- Biotissue Holdings Inc. : $2.1M total payments, HHI 90
- Kerecis Limited : $4.0M total payments, HHI 89
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Mid-Atlantic Surgical Systems, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Mid-Atlantic Surgical Systems, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Mid-Atlantic Surgical Systems, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Mitsubishi Tanabe Pharma Corporation
Banner Life Sciences, LLC
Okami Medical, Inc.
OnMark, Inc.
AGEPHA Pharma FZ LLC
Put this to use
Mid-Atlantic Surgical Systems, LLC ranks #1204 of 1,925 by all-tracks total payments, led by "Travel and Lodging".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Travel and Lodging" spend across every manufacturer, not just Mid-Atlantic Surgical Systems, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.